208 related articles for article (PubMed ID: 21993632)
21. Down-regulation of miR-5702 is associated with clinical progression and poor prognosis in patients with non-small-cell lung cancer.
Li K; Xu Y; Yuan LN
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2047-2052. PubMed ID: 30915748
[TBL] [Abstract][Full Text] [Related]
22. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-105 promotes epithelial-mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl-1.
Jin X; Yu Y; Zou Q; Wang M; Cui Y; Xie J; Wang Z
J Cell Biochem; 2019 Apr; 120(4):5880-5888. PubMed ID: 30317672
[TBL] [Abstract][Full Text] [Related]
24. High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.
Park KS; Moon YW; Raffeld M; Lee DH; Wang Y; Giaccone G
Lung Cancer; 2018 Feb; 116():38-45. PubMed ID: 29413049
[TBL] [Abstract][Full Text] [Related]
25. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer.
Fu Y; Li Y; Wang X; Li F; Lu Y
Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046
[TBL] [Abstract][Full Text] [Related]
29. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
31. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
32. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.
Pastuszak-Lewandoska D; Kordiak J; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz JM; Antczak A; Górski P; Brzeziańska-Lasota E
Med Oncol; 2016 Aug; 33(8):96. PubMed ID: 27447710
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G
Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
